Investigating pathogen biology at the level of the proteome

Phillip Cash

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Bacterial infections are a major cause of morbidity and mortality throughout the world. By extending our understanding of the process of bacterial pathogenesis at the molecular level new strategies for their treatment and prevention can be developed. Proteomic technologies, along with other methods for global gene expression analysis, play an important role in understanding the mechanism(s) of bacterial pathogenesis. This review highlights the use of proteomics to identify protein biomarkers for virulent bacterial isolates and how these biomarkers can be correlated with the outcome of bacterial infection. Biomarker identification typically looks at the proteomes of bacteria grown under laboratory conditions. It is, however, the characterisation of the bacterial proteome during in vivo infection of its host that will eventually provide the most significant insights into bacterial pathogenesis. Although this area of research has significant technical challenges, a number of complementary proteome analytical approaches are being developed to identify and characterise the bacterial genes specifically expressed in vivo. Ultimately, the development of new targeted therapies and vaccines using specific protein targets indentified through proteomic analyses will be one of the major practical benefits arising from the proteomic analysis of bacterial pathogens.
Original languageEnglish
Pages (from-to)190-202
Number of pages13
JournalProteomics
Volume11
Issue number15
Early online date4 Jul 2011
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Pathogens
Proteome
Proteomics
Biomarkers
Bacterial Infections
Bacterial Physiological Phenomena
Bacterial Genes
Active Immunotherapy
Gene expression
Bacteria
Proteins
Vaccines
Genes
Technology
Morbidity
Gene Expression
Mortality
Infection
Research
Therapeutics

Keywords

  • bacteria
  • bacterial pathogenesis
  • infectious diseases
  • microbiology

Cite this

Investigating pathogen biology at the level of the proteome. / Cash, Phillip.

In: Proteomics, Vol. 11, No. 15, 08.2011, p. 190-202.

Research output: Contribution to journalArticle

Cash, Phillip. / Investigating pathogen biology at the level of the proteome. In: Proteomics. 2011 ; Vol. 11, No. 15. pp. 190-202.
@article{a24c15b514ff49f598552a7c21cdb78b,
title = "Investigating pathogen biology at the level of the proteome",
abstract = "Bacterial infections are a major cause of morbidity and mortality throughout the world. By extending our understanding of the process of bacterial pathogenesis at the molecular level new strategies for their treatment and prevention can be developed. Proteomic technologies, along with other methods for global gene expression analysis, play an important role in understanding the mechanism(s) of bacterial pathogenesis. This review highlights the use of proteomics to identify protein biomarkers for virulent bacterial isolates and how these biomarkers can be correlated with the outcome of bacterial infection. Biomarker identification typically looks at the proteomes of bacteria grown under laboratory conditions. It is, however, the characterisation of the bacterial proteome during in vivo infection of its host that will eventually provide the most significant insights into bacterial pathogenesis. Although this area of research has significant technical challenges, a number of complementary proteome analytical approaches are being developed to identify and characterise the bacterial genes specifically expressed in vivo. Ultimately, the development of new targeted therapies and vaccines using specific protein targets indentified through proteomic analyses will be one of the major practical benefits arising from the proteomic analysis of bacterial pathogens.",
keywords = "bacteria, bacterial pathogenesis, infectious diseases, microbiology",
author = "Phillip Cash",
year = "2011",
month = "8",
doi = "10.1002/pmic.201100029",
language = "English",
volume = "11",
pages = "190--202",
journal = "Proteomics",
issn = "1615-9853",
publisher = "John Wiley & Sons, Ltd",
number = "15",

}

TY - JOUR

T1 - Investigating pathogen biology at the level of the proteome

AU - Cash, Phillip

PY - 2011/8

Y1 - 2011/8

N2 - Bacterial infections are a major cause of morbidity and mortality throughout the world. By extending our understanding of the process of bacterial pathogenesis at the molecular level new strategies for their treatment and prevention can be developed. Proteomic technologies, along with other methods for global gene expression analysis, play an important role in understanding the mechanism(s) of bacterial pathogenesis. This review highlights the use of proteomics to identify protein biomarkers for virulent bacterial isolates and how these biomarkers can be correlated with the outcome of bacterial infection. Biomarker identification typically looks at the proteomes of bacteria grown under laboratory conditions. It is, however, the characterisation of the bacterial proteome during in vivo infection of its host that will eventually provide the most significant insights into bacterial pathogenesis. Although this area of research has significant technical challenges, a number of complementary proteome analytical approaches are being developed to identify and characterise the bacterial genes specifically expressed in vivo. Ultimately, the development of new targeted therapies and vaccines using specific protein targets indentified through proteomic analyses will be one of the major practical benefits arising from the proteomic analysis of bacterial pathogens.

AB - Bacterial infections are a major cause of morbidity and mortality throughout the world. By extending our understanding of the process of bacterial pathogenesis at the molecular level new strategies for their treatment and prevention can be developed. Proteomic technologies, along with other methods for global gene expression analysis, play an important role in understanding the mechanism(s) of bacterial pathogenesis. This review highlights the use of proteomics to identify protein biomarkers for virulent bacterial isolates and how these biomarkers can be correlated with the outcome of bacterial infection. Biomarker identification typically looks at the proteomes of bacteria grown under laboratory conditions. It is, however, the characterisation of the bacterial proteome during in vivo infection of its host that will eventually provide the most significant insights into bacterial pathogenesis. Although this area of research has significant technical challenges, a number of complementary proteome analytical approaches are being developed to identify and characterise the bacterial genes specifically expressed in vivo. Ultimately, the development of new targeted therapies and vaccines using specific protein targets indentified through proteomic analyses will be one of the major practical benefits arising from the proteomic analysis of bacterial pathogens.

KW - bacteria

KW - bacterial pathogenesis

KW - infectious diseases

KW - microbiology

U2 - 10.1002/pmic.201100029

DO - 10.1002/pmic.201100029

M3 - Article

VL - 11

SP - 190

EP - 202

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 15

ER -